Skip to content

Drug interactions

Irinotecan + Ranolazine

Severity: Moderate

Irinotecan and Ranolazine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ranolazine inhibits P-glycoprotein, which may reduce efflux of irinotecan and its active metabolite SN-38. This could intensify diarrhea and neutropenia, although clinical evidence is limited.

What this interaction means in plain words

Irinotecan and Ranolazine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Irinotecan belongs to Oncology; Ranolazine belongs to Cardiovascular.

Evidence level: Low

Why it happens

P-glycoprotein inhibition by ranolazine may increase exposure to irinotecan and SN-38.

What to do

Monitor for severe diarrhea and neutropenia and check blood counts regularly. Reduce the irinotecan dose or hold treatment if grade 3 toxicity develops.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Irinotecan and Ranolazine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Irinotecan with Ranolazine?

MediHelp rates the interaction as moderate. Irinotecan and Ranolazine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Ranolazine inhibits P-glycoprotein, which may reduce efflux of irinotecan and its active metabolite SN-38. This could intensify diarrhea and neutropenia, although clinical evidence is limited.

How serious is the interaction between Irinotecan and Ranolazine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for severe diarrhea and neutropenia and check blood counts regularly. Reduce the irinotecan dose or hold treatment if grade 3 toxicity develops.

What other medicines interact with Ranolazine?

MediHelp also lists interactions of Ranolazine with, for example, Adagrasib, Amobarbital, Apalutamide. The full list is on the Ranolazine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in